Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Revenue

Agios Pharmaceuticals had revenue of $20.75M in the quarter ending March 31, 2026, with 137.75% growth. This brings the company's revenue in the last twelve months to $66.05M, up 78.34% year-over-year. In the year 2025, Agios Pharmaceuticals had annual revenue of $54.03M with 48.03% growth.

• Revenue (ttm): $66.05M
• Revenue Growth: +78.34%
• P/S Ratio: 24.82
• Revenue / Employee: $122,311
• Employees: 540
• Market Cap: 1.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	54.03M	17.53M	48.03%
Dec 31, 2024	36.50M	9.68M	36.07%
Dec 31, 2023	26.82M	12.58M	88.36%
Dec 31, 2022	14.24M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	94.39M	51.38M	119.45%
Dec 31, 2017	43.01M	-26.88M	-38.46%
Dec 31, 2016	69.89M	10.77M	18.22%
Dec 31, 2015	59.12M	-6.24M	-9.55%
Dec 31, 2014	65.36M	39.81M	155.82%
Dec 31, 2013	25.55M	442.00K	1.76%
Dec 31, 2012	25.11M	3.27M	14.97%
Dec 31, 2011	21.84M	-	-

Data Source: Fiscal.ai Last updated: Apr 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error